Claus R Riedl
Overview
Explore the profile of Claus R Riedl including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
269
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Barua J, Arance I, Angulo J, Riedl C
Int Urogynecol J
. 2015 Nov;
27(8):1137-47.
PMID: 26590137
Bladder pain syndrome/interstitial cystitis (BPS/IC) is a chronic disease characterised by persistent irritating micturition symptoms and pain. The objective was to compare the clinical efficacy of currently available products for...
2.
Engelhardt P, Seklehner S, Brustmann H, Riedl C, Lusuardi L
Minerva Urol Nefrol
. 2015 May;
68(3):242-9.
PMID: 26013949
Background: The aim of this study was to evaluate the incidence of prostatic calcification and prostatitis NIH category IV in patients with obstructive BPH. Methods: Ninety-six patients with obstructive BPH...
3.
Engelhardt P, Seklehner S, Brustmann H, Lusuardi L, Riedl C
Scand J Urol
. 2014 Nov;
49(2):120-6.
PMID: 25363611
Objective: This study prospectively investigated the immunohistochemical expression of interleukin-2 receptor (IL-2R) and interleukin-6 (IL-6) in patients with prostate cancer and benign prostatic hyperplasia (BPH), and a possible association of...
4.
Engelhardt P, Morakis N, Daha L, Esterbauer B, Riedl C
Int Urogynecol J
. 2010 Oct;
22(4):401-5.
PMID: 20938644
Introduction And Hypothesis: While the short-term efficacy of intravesical hyaluronan for bladder pain syndrome/interstitial cystitis (BPS/IC) has been demonstrated, no data exist on the long-term outcome of this therapy. Methods:...
5.
Daha L, Riedl C, Lazar D, Simak R, Pfluger H
Scand J Urol Nephrol
. 2009 Feb;
42(4):369-72.
PMID: 19230170
Objective: To evaluate changes in bladder capacity and potassium sensitivity after glycosaminoglycan (GAG) substitution therapy. Material And Methods: The study population comprised two groups of female patients with bladder pain...
6.
7.
Engelhardt P, Riedl C
Urology
. 2008 Mar;
71(2):185-90.
PMID: 18308079
Objectives: To asses the effect of an isoflavonoid extract from red clover on the prostate, liver function, quality of life, and sexual function in men with an initial elevated prostate-specific...
8.
Riedl C, Engelhardt P, Daha K, Morakis N, Pfluger H
Int Urogynecol J Pelvic Floor Dysfunct
. 2007 Dec;
19(5):717-21.
PMID: 18097627
The aim of this study is to evaluate the efficacy of intravesical hyaluronan therapy in interstitial cystitis/painful bladder syndrome (IC/PBS). One hundred twenty-six patients with IC/PBS and an average disease...
9.
Daniltchenko D, Riedl C, Sachs M, Koenig F, Daha K, Pflueger H, et al.
J Urol
. 2005 Nov;
174(6):2129-33, discussion 2133.
PMID: 16280742
Purpose: As shown in various studies 5-aminolevulinic acid (ALA) induces fluorescence of malignant and dysplastic bladder tissue and increases tumor detection rates by about 20%. However, data on the long-term...
10.
Riedl C, Sternig P, Galle G, Langmann F, Vcelar B, Vorauer K, et al.
Eur Urol
. 2005 Jun;
48(4):656-61.
PMID: 15982798
Objective: To demonstrate the efficacy and safety of a topical gel containing liposomally encapsulated recombinant human Superoxide Dismutase (lrhSOD) in the treatment of painful Peyronie's Disease. The theoretical background is...